Abbott Laboratories (ABT)
NYSE · Healthcare
Abbott Laboratories Operating Income 2007–2025
Abbott Laboratories annual/quarterly operating income history and growth rate from 2007 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Abbott Laboratories operating income for the quarter ending March 31, 2026 was 1.3 B, a 20.56% decrease year-over-year.
- Abbott Laboratories operating income for the twelve months ending March 31, 2026 was 7.1 B, a 8.93% increase year-over-year.
- Abbott Laboratories annual operating income for 2025 was 8.1 B, a 17.99% increase from 2024.
- Abbott Laboratories annual operating income for 2024 was 6.8 B, a 5.36% increase from 2023.
- Abbott Laboratories annual operating income for 2023 was 6.5 B, a 22.53% decrease from 2022.
- Abbott Laboratories annual operating income for 2022 was 8.4 B.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Abbott Laboratories Operating Income — FAQ
Abbott Laboratories (ABT) operating income over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
What is Abbott Laboratories's operating income?
Abbott Laboratories (ABT) reported operating income of $8.05B for fiscal 2025.
Where can I see ABT's operating income history?
The chart and table above show Abbott Laboratories's operating income by year and by quarter, including the growth rate.